3 terminated. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Terminated 3 |
Follow Tinea: new trials by email Literature Review of Tinea trials Research Report on Tinea
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety & Efficacy of NAB001 in the Treatment of Mild to Moderate Onychomycosis of the Toenails NAB001, Vehicle alone - Onychomycosis | Phase 3 | Terminated | Promius Pharma, LLC | 468 | 2010-09-01 | 2013-07-11 |
| Safety and Efficacy of NAB001 in the Treatment of Mild to Moderate Onychomycosis of the Toenails NAB001, Placebo control - Onychomycosis | Phase 3 | Terminated | Promius Pharma, LLC | 458 | 2010-09-01 | 2013-07-11 |
| An Efficacy Study of a New Formulation of Ketoconazole 2% Cream in Patients With Tinea Pedis, Commonly Known as Athlete's Foot Placebo cream, Ketoconazole 2% cream (formulation F012) (Nizoral), Ketoconazole 2% cream (formulation F126) - Tinea Pedis | Phase 3 | Terminated | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 583 | 2007-07-01 | 2014-04-29 |
Onychomycosis (2) · Tinea Pedis (1)
Bacterial Infections and Mycoses (3) · Dermatomycoses (3) · Infections (3) · Mycoses (3) · Skin Diseases (3) · Skin Diseases, Infectious (3) · Skin and Connective Tissue Diseases (3) · Nail Diseases (2) · Foot Dermatoses (1) · Foot Diseases (1) · Pathological Conditions, Signs and Symptoms (1) · Pruritus (1) · Signs and Symptoms (1) · Skin Manifestations (1)
Ketoconazole (1)
Promius Pharma, LLC (2) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (1)
United States (2) · Dominican Republic (1) · Poland (1) · United Kingdom (1)
Joanne Fraser, PhD (2) · Kent Allenby, MD (2)